2024 HEMATOLOGY AND ONCOLOGY BEST PRACTICES – FULL SESSION The most comprehensive board review for physicians preparing to take the Hematology and Oncology certification exams or those desiring a comprehensive update of hematology and medical oncology standards of care.
COURSE OVERVIEW
2024 HEMONC Best Practices Course Syllabus- Full Session.pdf
COURSE CONTENT
This online course is divided into 3 modules:
Hematology Sessions:
- Home Study/Enduring Sessions: Anemias, Porphyrias, Red Cell Enzymes, Clotting and Cellular Morphology (4.00 hours)
- Live Session 1: Hemolytic Anemia, ITP Drug-Induced Thromboycytopenia, Consumptive Thrombohemorrhagic Disorders, Transfusion Medicine and Platelet Alloimmunization (9.00 hours)
- Live Session 2: Hemoglobinopathies, White Cell Disorders, Bone Marrow Failure, Sickle Cell Disease, DIC, Anti-PF4 Disorders and Hematologic Complications of Pregnancy (8.75 hours)
Hematologic Malignancies Sessions:
- Live Session 3: Lymphomas, CLL, ALL, CML, Plasma Cell Disorders, and MGUS (9.25 hours)
- Live Session 4: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasms and Pharmacology (9.25 hours)
Medical Oncology Sessions:
- Live Session 5: Breast Cancer, Renal Cancer, Bladder, and Neuro-Oncology (9.00 hours)
- Live Session 6: Lung Cancer, Prostate, Testicular, Mesothelioma, Ovarian and Endometrial Tumors (10.00 hours)
- Live Session 7: GI Oncology and Sarcomas (6.75 hours)
COURSE FEATURES
All registered attendees receive:
- A comprehensive review of Hematology and Oncology exam-focused content guided by the ABIM exam blueprint
- Instruction by the nation’s leading clinician-educators
- Daily Board Review Sessions- Allows attendees to gauge their knowledge base and become familiar with Interactive case-based board-type questions
- Access to Course Electronic Syllabus and Slide Handouts
- Access to the archived course recordings until Wednesday, December 31, 2025
- All content can be conveniently accessed from your computer, mobile device, or smartphone
- CME credits and MOC points
LEARNING OBJECTIVES
At the conclusion of the Hematology and Oncology Best Practices course, the successful learner will be able to:
Hematology
- Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors
- Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
- Understand blood and marrow morphology and hematopathology
- Understand red cell disorders
Hematologic Malignancies
- Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
- Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
- Identify strategies for taking the board examinations
Oncology
- Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
- Comprehend the principles of management of gynecologic and other genito-urinary malignancies
- Identify the latest advances in cancers of the lung, the breast, and the gastrointestinal tract
- Recognize principles of new developments in biologic therapy of cancer
